| 000 | 01925 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250518091809.0 | ||
| 264 | 0 | _c20201109 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a2051-1426 | ||
| 024 | 7 |
_a10.1136/jitc-2020-000713 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMinchom, Anna | |
| 245 | 0 | 0 |
_aMolecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab. _h[electronic resource] |
| 260 |
_bJournal for immunotherapy of cancer _c03 2020 |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aB7-H1 Antigen _xanalysis |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aMesothelioma _xdrug therapy |
| 650 | 0 | 4 | _aMesothelioma, Malignant |
| 650 | 0 | 4 |
_aPleural Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRetreatment _xmethods |
| 700 | 1 | _aYuan, Wei | |
| 700 | 1 | _aCrespo, Mateus | |
| 700 | 1 | _aGurel, Bora | |
| 700 | 1 | _aFigueiredo, Ines | |
| 700 | 1 | _aWotherspoon, Andrew | |
| 700 | 1 | _aMiranda, Susana | |
| 700 | 1 | _aRiisnaes, Ruth | |
| 700 | 1 | _aFerreira, Ana | |
| 700 | 1 | _aBertan, Claudia | |
| 700 | 1 | _aPereira, Rita | |
| 700 | 1 | _aClarke, Matt | |
| 700 | 1 | _aBaker, Chloe | |
| 700 | 1 | _aAng, Joo Ern | |
| 700 | 1 | _aFotiadis, Nicos | |
| 700 | 1 | _aTunariu, Nina | |
| 700 | 1 | _aCarreira, Suzanne | |
| 700 | 1 | _aPopat, Sanjay | |
| 700 | 1 | _aO'Brien, Mary | |
| 700 | 1 | _aBanerji, Udai | |
| 700 | 1 | _ade Bono, Johann | |
| 700 | 1 | _aLopez, Juanita | |
| 773 | 0 |
_tJournal for immunotherapy of cancer _gvol. 8 _gno. 1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/jitc-2020-000713 _zAvailable from publisher's website |
| 999 |
_c30740113 _d30740113 |
||